Colgate-Palmolive Company (CL)

Basic

  • Market Cap

    $63.96B

  • EV

    $71.9B

  • Shares Out

    823.37M

  • Revenue

    $19.14B

  • Employees

    33,800

Margins

  • Gross

    57.23%

  • EBITDA

    21.27%

  • Operating

    18.39%

  • Pre-Tax

    13.25%

  • Net

    8.29%

  • FCF

    13.34%

Returns (5Yr Avg)

  • ROA

    16.21%

  • ROE

    490.56%

  • ROCE

    35.54%

  • ROIC

    26.1%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $81.85

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $23.06

  • Earnings (Dil)

    $1.9

  • FCF

    $3.07

  • Book Value

    -$0.01

Growth (CAGR)

  • Rev 3Yr

    5.79%

  • Rev 5Yr

    4.14%

  • Rev 10Yr

    0.99%

  • Dil EPS 3Yr

    -15.27%

  • Dil EPS 5Yr

    -4.65%

  • Dil EPS 10Yr

    -2.29%

  • Rev Fwd 2Yr

    5.4%

  • EBITDA Fwd 2Yr

    7.34%

  • EPS Fwd 2Yr

    7.66%

  • EPS LT Growth Est

    7.52%

Dividends

  • Yield

  • Payout

    99.34%

  • DPS

    $1.9

  • DPS Growth 3Yr

    2.98%

  • DPS Growth 5Yr

    2.99%

  • DPS Growth 10Yr

    3.87%

  • DPS Growth Fwd 2Yr

    4.63%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Total Revenues

15,544.0

15,693.0

16,471.0

17,421.0

17,967.0

19,136.0

Total Revenues % Chg.

0.6%

1.0%

5.0%

5.8%

3.1%

7.9%

Cost of Goods Sold, Total

6,282.0

6,357.0

6,454.0

7,046.0

7,719.0

8,185.0

Gross Profit

9,262.0

9,336.0

10,017.0

10,375.0

10,248.0

10,951.0

Selling General & Admin Expenses, Total

5,434.0

5,616.0

6,093.0

6,477.0

6,625.0

7,325.0

Other Operating Expenses

69.0

76.0

136.0

77.0

19.0

107.0

Other Operating Expenses, Total

5,503.0

5,692.0

6,229.0

6,554.0

6,644.0

7,432.0

Operating Income

3,759.0

3,644.0

3,788.0

3,821.0

3,604.0

3,519.0

Interest Expense, Total

-193.0

-192.0

-183.0

-117.0

-167.0

-239.0

Interest And Investment Income

50.0

47.0

19.0

17.0

14.0

14.0

Net Interest Expenses

-143.0

-145.0

-164.0

-100.0

-153.0

-225.0

Income (Loss) On Equity Invest.

10.0

9.0

12.0

12.0

12.0

12.0

EBT, Excl. Unusual Items

3,626.0

3,508.0

3,636.0

3,733.0

3,463.0

3,306.0

Restructuring Charges

-161.0

-132.0

13.0

-110.0

-47.0

Merger & Related Restructuring Charges

-24.0

-2.0

-19.0

-2.0

Impairment of Goodwill

-367.0

-332.0

-332.0

Gain (Loss) On Sale Of Investments

-1.0

-51.0

Gain (Loss) On Sale Of Assets

47.0

Asset Writedown

-204.0

-389.0

-389.0

Legal Settlements

Other Unusual Items

-75.0

EBT, Incl. Unusual Items

3,464.0

3,301.0

3,647.0

3,087.0

2,660.0

2,536.0

Income Tax Expense

906.0

774.0

787.0

749.0

693.0

798.0

Earnings From Continuing Operations

2,558.0

2,527.0

2,860.0

2,338.0

1,967.0

1,738.0

Extraordinary Item & Accounting Change

Minority Interest

-158.0

-160.0

-165.0

-172.0

-182.0

-151.0

Net Income

2,400.0

2,367.0

2,695.0

2,166.0

1,785.0

1,587.0

Net Income to Common Incl Extra Items

2,400.0

2,367.0

2,695.0

2,166.0

1,785.0

1,587.0

Net Income to Common Excl. Extra Items

2,400.0

2,367.0

2,695.0

2,166.0

1,785.0

1,587.0

Total Shares Outstanding

862.9

854.7

849.9

840.5

830.2

823.4

Weighted Avg. Shares Outstanding

870.6

859.1

856.8

845.0

836.4

829.7

Weighted Avg. Shares Outstanding Dil

873.0

861.1

859.3

848.3

838.8

831.4

EPS

2.8

2.8

3.1

2.6

2.1

1.9

EPS Diluted

2.8

2.8

3.1

2.6

2.1

1.9

EBITDA

4,268.0

4,163.0

4,327.0

4,377.0

4,149.0

4,071.0